Porphyromonas gingivalis virulence proteins

Porphyromonas gingivalis virulence proteins are a group of specialized molecules, most notably the gingipains (Kgp, RgpA, and RgpB), that are critical for the survival and pathogenicity of the keystone oral pathogen P. gingivalis (Potempa et al., 2003). These proteins function primarily as cysteine proteases that degrade host tissues, provide essential nutrients by acquiring heme, and subvert the host immune system by cleaving cytokines and complement factors (Hajishengallis, 2014). Beyond their established role in chronic periodontitis, these virulence factors have been implicated in the pathogenesis of systemic conditions, most significantly Alzheimer's disease, where gingipains have been identified in the brains of patients and linked to neurotoxicity (Dominy et al., 2019). Therapeutic efforts have focused on developing small-molecule inhibitors, such as atuzaginstat, designed to neutralize these proteases and mitigate both local and systemic inflammatory damage. While clinical development has faced challenges including safety concerns related to liver toxicity, these proteins remain a high-interest target for treating infection-driven inflammatory diseases.

Other names

P. gingivalis virulence factorsGingipainsLysine-specific gingipain (Kgp)Arginine-specific gingipain A (RgpA)Arginine-specific gingipain B (RgpB)Peptidylarginine deiminase (PPAD)Fimbriae

Small-molecule inhibition of lysine-specific and arginine-specific cysteine proteases (gingipains) to disrupt bacterial nutrient acquisition, host tissue degradation, and immune subversion (Potempa et al., 2003; Dominy et al., 2019).